9-77307991-A-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_033305.3(VPS13A):c.4007A>T(p.His1336Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000326 in 1,602,988 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_033305.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
VPS13A | NM_033305.3 | c.4007A>T | p.His1336Leu | missense_variant | 35/72 | ENST00000360280.8 | |
VPS13A | NM_001018037.2 | c.3890A>T | p.His1297Leu | missense_variant | 34/71 | ||
VPS13A | NM_015186.4 | c.4007A>T | p.His1336Leu | missense_variant | 35/69 | ||
VPS13A | NM_001018038.3 | c.4007A>T | p.His1336Leu | missense_variant | 35/69 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
VPS13A | ENST00000360280.8 | c.4007A>T | p.His1336Leu | missense_variant | 35/72 | 1 | NM_033305.3 | P4 |
Frequencies
GnomAD3 genomes AF: 0.00178 AC: 271AN: 152132Hom.: 2 Cov.: 32
GnomAD3 exomes AF: 0.000502 AC: 126AN: 250952Hom.: 1 AF XY: 0.000339 AC XY: 46AN XY: 135620
GnomAD4 exome AF: 0.000174 AC: 252AN: 1450738Hom.: 2 Cov.: 32 AF XY: 0.000166 AC XY: 120AN XY: 722484
GnomAD4 genome AF: 0.00178 AC: 271AN: 152250Hom.: 2 Cov.: 32 AF XY: 0.00180 AC XY: 134AN XY: 74454
ClinVar
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 28, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Jul 26, 2023 | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 01, 2022 | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Chorea-acanthocytosis Benign:1
Benign, no assertion criteria provided | clinical testing | Natera, Inc. | Nov 11, 2019 | - - |
VPS13A-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 30, 2020 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at